Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

DarioHealth (DRIO) Return on Capital Employed (2016 - 2025)

DarioHealth filings provide 13 years of Return on Capital Employed readings, the most recent being 35.05% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 2400.0% to 35.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 35.05%, a 2400.0% increase, with the full-year FY2025 number at 34.86%, up 2860.0% from a year prior.
  • Return on Capital Employed hit 35.05% in Q4 2025 for DarioHealth, up from 38.32% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 35.05% in Q4 2025 to a low of 80.86% in Q4 2021.
  • Median Return on Capital Employed over the past 5 years was 56.24% (2024), compared with a mean of 55.3%.
  • Biggest five-year swings in Return on Capital Employed: soared 11021bps in 2021 and later crashed -2717bps in 2022.
  • DarioHealth's Return on Capital Employed stood at 80.86% in 2021, then soared by 32bps to 54.94% in 2022, then decreased by -15bps to 63.17% in 2023, then increased by 7bps to 59.05% in 2024, then skyrocketed by 41bps to 35.05% in 2025.
  • The last three reported values for Return on Capital Employed were 35.05% (Q4 2025), 38.32% (Q3 2025), and 41.39% (Q2 2025) per Business Quant data.